| RGNX YTD Return Table | ||||||||||||||||||||||||||||||
RGNX YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare RGNX YTD return (see YTD Return Meaning) versus benchmarks: YTD Return S&P YTD Return Dow YTD Return Nasdaq 100 YTD Return Russell 2000 YTD Return Gold YTD Return 10 Year Treasury YTD Return By Sector |
| RGNX Share Performance |
| RGNX YTD Return Chart | |||
Also see: RGNX Average Annual Return | |||
| About REGENXBIO Inc |
| REGENXBIO is a clinical-stage biotechnology company. Co.'s product candidates include: RGX-314, which is being developed as a gene therapy for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other additional chronic retinal conditions which cause total or partial vision loss for patients in the U.S., Europe and Japan; RGX-121, which is for the treatment of Mucopolysaccharidosis Type II; RGX-111, which is for the treatment of Mucopolysaccharidosis Type I; RGX-181, which is for the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease; and RGX-381, which is for the treatment of ocular manifestations of CLN2 disease. The RGNX YTD return is shown above.
The YTD Return on the RGNX YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether RGNX YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the RGNX YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| RGNX Current Stock Quote |
 Free RGNX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| REGENXBIO (RGNX) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
RIGL YTD Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.
Video: Don't Forget Dividends in YTD Return!